DrugPatentWatch Database Preview
AMELUZ Drug Profile
see a sample report or, see our see our flat-rate plans
When do Ameluz patents expire, and what generic alternatives are available?
This drug has thirteen patent family members in eleven countries.
The generic ingredient in AMELUZ is aminolevulinic acid hydrochloride. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the aminolevulinic acid hydrochloride profile page.
Summary for AMELUZ
| International Patents: | 13 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 101 |
| Clinical Trials: | 9 |
| Patent Applications: | 148 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | AMELUZ at DailyMed |
Pharmacology for AMELUZ
| Ingredient-type | Porphyrinogens |
| Drug Class | Porphyrin Precursor |
Medical Subject Heading (MeSH) Categories for AMELUZ
Synonyms for AMELUZ
| .delta.-Aminolevulinic acid hydrochloride |
| 0C1E43DB-1221-4963-BFA4-18D3170000A4 |
| 4-carboxy-2-oxobutan-1-aminium chloride |
| 451A092 |
| 5 ALA HCL |
| 5-amino levulinic acid hydrochloride |
| 5-Amino-3-oxopentanoic acid (hydrochloride) |
| 5-amino-4-keto-valeric acid |
| 5-Amino-4-ketovaleric acid hydrochloride |
| 5-AMINO-4-OXOPENTANOIC ACID HCL |
| 5-Amino-4-oxopentanoic acid hydrochloride |
| 5-amino-4-oxopentanoic acid hydrochloride;5-Amino-4-oxopentanoic acid |
| 5-amino-4-oxopentanoic acid, chloride |
| 5-Amino-4-oxovaleric acid hydrochloride |
| 5-amino-levulinic acid hydrochloride |
| 5-Aminolaevulinic acid hydrochloride |
| 5-Aminolevulinate hydrochloride |
| 5-Aminolevulinic acid (hydrochloride) |
| 5-Aminolevulinic acid HCl |
| 5-Aminolevulinic acid hydrochloride |
| 5-aminolevulinic acid hydrochloride salt |
| 5-Aminolevulinic acid hydrochloride, >=97.0% (AT) |
| 5-Aminolevulinic acid hydrochloride, >=98% |
| 5-Aminolevulinic acid hydrochloride, BioReagent, suitable for cell culture, powder, >=98% |
| 5-Aminolevulinic acid hydrochloride, GMP |
| 5-Aminolevulinic acid hydrochloride, particle size < 0.25 mm |
| 5-Aminolevulinic Acid, Hydrochloride Salt |
| 5-aminolevulinic acid.HCl |
| 5451-09-2 |
| A-6100 |
| A-6102 |
| A-6103 |
| A0325 |
| AB1005459 |
| AC-4252 |
| AC1L3WYV |
| AC1Q5HEA |
| ACT05562 |
| AK-30504 |
| AKOS015904495 |
| ALA HCl |
| ALA-PDT |
| AlaCare |
| AM20100341 |
| Ameluz (TN) |
| Aminolevulinic Acid HCl |
| Aminolevulinic acid hydrochloride |
| Aminolevulinic acid hydrochloride (JAN/USAN) |
| Aminolevulinic acid hydrochloride [USAN] |
| Aminolevulinic acid hydrochloride, United States Pharmacopeia (USP) Reference Standard |
| ANW-43114 |
| AT-6127 |
| AX8102341 |
| BC210778 |
| BCP9000174 |
| BR-30504 |
| C-04944 |
| C5H9NO3.HCl |
| CA-291 |
| CAS-5451-09-2 |
| CC-21174 |
| CCG-39079 |
| CHEBI:132969 |
| CHEMBL1200582 |
| CS-2575 |
| CTK1G9933 |
| D02908 |
| D0O4GY |
| DB-005367 |
| delta-Aminolevulinic acid hydrochloride |
| DSSTox_CID_25914 |
| DSSTox_GSID_45914 |
| DSSTox_RID_81222 |
| DTXSID5045914 |
| EINECS 226-679-5 |
| FT-0082845 |
| Gleolan |
| Gliolan |
| GM8475 |
| GS-3020 |
| HMS1922F13 |
| HY-N0305 |
| I14-1649 |
| KB-196689 |
| KB-244625 |
| KS-000001DZ |
| KSC269S3H |
| Levulan |
| Levulan (TN) |
| Levulan Kerastick |
| Levulinic acid, 5-amino-, hydrochloride |
| Levulinic acid, 5-amino-, hydrochloride (8CI) |
| LS-87948 |
| M-2865 |
| MCULE-8125179397 |
| MFCD00012869 |
| MolPort-001-757-321 |
| NCGC00095111-01 |
| NCGC00095111-02 |
| NCGC00095111-03 |
| NCGC00178086-03 |
| NSC 18509 |
| NSC-18509 |
| NSC-758687 |
| NSC18509 |
| NSC758687 |
| OR002139 |
| OR1490 |
| PD-P-506-A |
| Pentanoic acid, 5-amino-4-oxo-, hydrochloride |
| Pentanoic acid, hydrochloride |
| Pentanoicacid, 5-amino-4-oxo-, hydrochloride (1:1) |
| Pharmakon1600-01504184 |
| RL04038 |
| RP23037 |
| RTR-019277 |
| S2553 |
| SBB003880 |
| SC-18502 |
| SC-52394 |
| SCHEMBL192308 |
| SPECTRUM1504184 |
| ST2411714 |
| ST50824911 |
| Tox21_111426 |
| Tox21_111426_1 |
| TPC-I025 |
| TR-019277 |
| UNII-V35KBM8JGR |
| V35KBM8JGR |
| ZLHFONARZHCSET-UHFFFAOYSA-N |
| ZX-AT009947 |
US Patents and Regulatory Information for AMELUZ
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biofrontera | AMELUZ | aminolevulinic acid hydrochloride | GEL;TOPICAL | 208081-001 | May 10, 2016 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Biofrontera | AMELUZ | aminolevulinic acid hydrochloride | GEL;TOPICAL | 208081-001 | May 10, 2016 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
International Patents for AMELUZ
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Canada | 2351620 | ➤ Try a Free Trial |
| Australia | 758098 | ➤ Try a Free Trial |
| South Africa | 200104726 | ➤ Try a Free Trial |
| Austria | 260092 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
